Buscar en
Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica (English Edition) Use of ribavirin in viruses other than hepatitis C. A review of the evidence
Journal Information
Share
Share
Download PDF
More article options
Visits
2025
Review article
Use of ribavirin in viruses other than hepatitis C. A review of the evidence
Uso de ribavirina en virus distintos de la hepatitis C. Una revisión de la evidencia
Visits
2025
German Ramírez-Olivencia
Corresponding author
germano.76@gmail.com

Corresponding author.
, Miriam Estébanez, Francisco Javier Membrillo, Maria del Carmen Ybarra
Unidad de Aislamiento de Alto Nivel, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain
This item has received
Received 16 January 2018. Accepted 08 May 2018
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (4)
Table 1. Notifications of isolated cases of disease due to adenovirus treated with ribavirin.
Table 2. Case series of disease due to adenovirus treated with ribavirin.
Table 3. Cases of disease due to MERS-CoV treated with ribavirin.
Table 4. Case series of disease due to MERS-CoV treated with ribavirin (+ IFN).
Show moreShow less
Abstract

Ribavirin is a molecule with antiviral activity against different viruses. In clinical practice, it has made its niche almost exclusively for the treatment of the hepatitis C virus. However, there are other diseases in which it could be of benefit and it has the advantage of being suitable for oral, intravenous and inhaled administration. We conducted a review of the indications of the main drug agencies (Spanish, European and American) and other possible indications, mainly haemorrhagic fevers and coronavirus.

Keywords:
Ribavirin
Virazole
1-f8-d-Ribofuranosyl-1,2,4-triazole-3-carboxamide
Resumen

La ribavirina es una molécula con actividad antiviral sobre diferentes virus. Ha encontrado su hueco en la práctica clínica de forma casi exclusiva para el tratamiento del virus de la hepatitis C, pero existen otras enfermedades que podrían beneficiarse de su empleo. Su disponibilidad para administración por vía oral, por vía intravenosa e inhalada es una característica beneficiosa. En este trabajo se realiza una revisión de las indicaciones en las principales agencias del medicamento (española, europea y americana), así como de otras posibles indicaciones, principalmente sobre fiebres hemorrágicas y coronavirus.

Palabras clave:
Ribavirina
Virazole
1-f8-d-Ribofuranosil-1,2,4-triazol-3-carboxamida

Article

These are the options to access the full texts of the publication Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Member

Socio de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica

Para acceder a la revista

Es necesario que lo haga desde la zona privada de la web de la SEIMC, clique aquí

Para realizar los cursos formativos

La actividad estará abierta para socios de la SEIMC. IMPORTANTE, recuerde que requiere registro previo gratuito. Empezar aquí

Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Enfermedades Infecciosas y Microbiología Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos